KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Equity (2016 - 2025)

Jazz Pharmaceuticals has reported Return on Equity over the past 15 years, most recently at 0.06% for Q4 2025.

  • Quarterly Return on Equity fell 20.0% to 0.06% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.06% through Dec 2025, down 20.0% year-over-year, with the annual reading at 0.08% for FY2025, 23.0% down from the prior year.
  • Return on Equity was 0.06% for Q4 2025 at Jazz Pharmaceuticals, up from 0.07% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.14% in Q1 2025 and troughed at 0.12% in Q1 2022.
  • The 5-year median for Return on Equity is 0.01% (2022), against an average of 0.01%.
  • Biggest five-year swings in Return on Equity: decreased -26bps in 2022 and later rose 19bps in 2023.
  • Tracing JAZZ's Return on Equity over 5 years: stood at 0.08% in 2021, then rose by 12bps to 0.07% in 2022, then surged by 257bps to 0.12% in 2023, then grew by 18bps to 0.14% in 2024, then crashed by -147bps to 0.06% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.06%, 0.07%, and 0.08% for Q4 2025, Q3 2025, and Q2 2025 respectively.